36824-00-7

Usage

Uses

Used in Flavor and Fragrance Industry:
4-(2-METHOXY-ETHOXY)-BENZALDEHYDE is used as a flavor and fragrance ingredient for its ability to impart a pleasant aroma and taste to foods, perfumes, and cosmetics. Its sweet and aromatic characteristics make it a valuable addition in creating desirable sensory experiences in these products.
Used in Pharmaceutical Industry:
4-(2-METHOXY-ETHOXY)-BENZALDEHYDE is used as an intermediate in the synthesis of pharmaceuticals for its role in the production of various organic compounds. Its chemical structure allows it to be a key component in the development of new medications.
Used in Antimicrobial Applications:
4-(2-METHOXY-ETHOXY)-BENZALDEHYDE is used as an antimicrobial agent for its potential to inhibit the growth of certain microorganisms. This property makes it a candidate for use in products where microbial control is necessary.
Used in Antifungal Applications:
4-(2-METHOXY-ETHOXY)-BENZALDEHYDE is used as an antifungal agent for its potential to prevent the growth of fungi, which is particularly important in various consumer products to maintain their quality and safety.
Used in Antioxidant Applications:
4-(2-METHOXY-ETHOXY)-BENZALDEHYDE is used as an antioxidant for its potential to protect against oxidative damage. This can be beneficial in extending the shelf life of products and protecting them from degradation.
Overall, 4-(2-METHOXY-ETHOXY)-BENZALDEHYDE, or Veratraldehyde, is a multifunctional chemical with a wide range of applications across different industries, from enhancing sensory experiences in food and cosmetics to serving as a building block in pharmaceutical development and providing protection against microbial and oxidative threats. Its use is considered safe when adhering to regulatory guidelines, making it a valuable asset in various consumer products.

InChI:InChI=1/C10H12O3/c1-12-6-7-13-10-4-2-9(8-11)3-5-10/h2-5,8H,6-7H2,1H3

Upstream product

• 627-42-9 2-chloroethyl methyl ether 
• 123-08-0 4-hydroxy-benzaldehyde 
• 6482-24-2 2-Bromoethyl methyl ether 
• 90-02-8 salicylaldehyde 
• 584-08-7 potassium carbonate 

Downstream Products

• 79407-30-0 [4-(2-methoxyethoxy)phenyl]methanol 
• 952189-03-6 6-[4-(2-methoxyethoxy)phenyl]fulvene 
• 544417-71-2 2-amino-4-[4-(2-methoxyethoxy)phenyl]-6-sulfanylpyridine-3,5-dicarbonitrile 
• 1189045-04-2 5-(4-(2-methoxyethoxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione 
• 1189045-09-7 5-(4-(2-methoxyethoxy)benzylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione 
• 1580440-74-9 2-chloro-5-(4-(2-methoxyethoxy)benzyl)pyrimidine 
• 1580440-75-0 ethyl 4-fluoro-1-(5-(4-(2-methoxyethoxy)benzyl)pyrimidin-2-yl)piperidine-4-carboxylate 
• 1580440-73-8 N'-(4-(2-methoxyethoxy)benzylidene)-4-methylbenzenesulfonohydrazide 

Relevant academic research and scientific papers

Rapid microwave-assisted synthesis of phenyl ethers under mildly basic and nonaqueous conditions

Microwave-assisted alkylation of phenols can be achieved within short reaction times under mild conditions using K2CO3 as a base, in methanol as a solvent. The method is suitable for base sensitive compounds or partially water-solubl

Styryl xanthine derivatives and uses thereof (by machine translation)

The invention discloses styryl xanthine derivatives and application, and particularly, relates to a novel styryl xanthine derivative and a pharmaceutical composition containing the same, and can be used as selective adenosine A. 2A Are antagoni

HETEROARYL INHIBITORS OF PAD4

The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.

Arginase inhibitor, preparation method thereof and application of arginase inhibitor

The invention belongs to the technical field of medicines, in particular to an arginase inhibitor and a preparation method thereof and an application of the arginase inhibitor. A compound serves as asmall-molecule treatment agent of a strong inhibitor of

Homoserine lactone derivatives, preparation method thereof and pharmaceutical composition for prevention or treatment of the periodontal diseases containing the same as an active ingredient

The present invention relates to homoserine lactone derivatives, optical isomers of the same, or pharmaceutically acceptable salts of the same. The homoserine lactone derivatives in the present invention have excellent properties as a quorum sensing antagonist which hinders communications among bacteria. According to the present invention, the homoserine lactone derivatives can hinder gene expressions of bacteria while effectively blocking formation of biofilm which is known to raise resistance against antibiotics, and suppress propagation of bacteria, thereby being useful as a pharmaceutical composition for preventing or treating periodontal diseases.

NOVEL SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND THEIR USE

The invention relates to activators of soluble guanylate cyclase of formula (I) and their use in pharmaceutical compositions, primarily topically administered ophthalmic compositions. The pharmaceutical compositions are useful for reducing intraocular pre

PIPERIDINE-DIONE DERIVATIVES

The invention provides novel compounds having the general formula (I) and tautomers and pharmaceutically acceptable salts thereof, wherein A1, A2, A3, A4, R1, R4, R5, R6, R7 and R8 are as defined herein, compositions including the compounds and methods of using the compounds.

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.

USE OF ADENOSINE A1 RECEPTOR AGONISTS FOR THE PROTECTION OF RENAL CELLS AGAINST TOXIC EFFECTS CAUSED BY AMINOGLYCOSIDES DURING TREATMENT OF INFECTIOUS DISEASES

The present invention refers to the use of adenosine Al receptor agonists for the protection of renal cells against toxic effects caused by aminoglycosides during treatment of infectious diseases in human.

Imidazole derivatives

The present invention relates to the imidazole derivative of the following formula (I) wherein R1 is hydrogen, optionally substituted alkyl and the like, R2 is hydrogen, optionally substituted alkyl and the like, R3is optionally substituted heteroaryl, R4 is optionally substituted cycloalkyl, optionally substituted phenyl and the like, provided that when R1 is hydrogen, and R2 and R4 are the same or different and each is phenyl or phenyl substituted by halogen atom, lower alkyl or lower alkoxy, R3 is benzothiazolyl or thiazolyl substituted by phenyl, the imidazole derivative of the following formula (XII) wherein R6 is optionally substituted phenyl or optionally substituted heteroaryl and R7 is substituted phenyl, and pharmaceutically acceptable salts thereof. The compounds of the formulas (I) and (XII) and pharmaceutically acceptable salts thereof of the present invention inhibit IL-4 and IL-5 production by Th2 cells and are effective for the prophylaxis and treatment of allergic diseases such as atopic dermatitis, bronchial asthma, allergic rhinitis and the like.